Two-year follow-up data from the STEPP-AMI study: A prospective, observational, multicenter study comparing tenecteplase-facilitated PCI versus primary PCI in Indian patients with STEMI
Background: A pharmacoinvasive strategy may alleviate the logistical and geographical barriers in timely reperfusion of ST-segment elevation myocardial infarction (STEMI), especially in a developing country like India. Aim: To assess the safety and efficacy of pharmacoinvasive strategy versus primar...
Main Authors: | Suma M. Victor, S. Vijayakumar, Thomas Alexander, C.G. Bahuleyan, Arun Srinivas, S. Selvamani, S. Marutha Priya, K. Kamaleswari, Ajit S. Mullasari |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-03-01
|
Series: | Indian Heart Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0019483215003715 |
Similar Items
-
The impact of systems-of-care on pharmacoinvasive management with streptokinase: The subgroup analysis of the TN-STEMI programme
by: Deep Chandh Raja, et al.
Published: (2017-09-01) -
Pharmacoinvasive Strategy in Acute STEMI
by: Isman Firdaus
Published: (2013-06-01) -
Metrics of care and cardiovascular outcomes in patients with ST-elevation myocardial infarction treated with pharmacoinvasive strategy: a decade-long network in a populous city in Brazil
by: Pedro Ivo De Marqui Moraes, et al.
Published: (2023-06-01) -
Outcome of primary PCI – An Indian tertiary care center experience
by: Vijayakumar Subban, et al.
Published: (2014-01-01) -
Real-World Evaluation of a Pharmacoinvasive Strategy for STEMI in Latin America: A Cost-Effective Approach with Short-Term Benefits
by: Arias-Mendoza A, et al.
Published: (2023-11-01)